Skip to main content

Annual Report 2023

Discover BioWin’s strategy, activities, projects as well as the performance of the Walloon ecosystem in the Annual Report 2023. This report is a reflection of the innovative and inspiring spirit of businesses and industries in Wallonia, Belgium, working daily for the benefit of patients. Despite the economic challenges of 2023,...
Read More

Syngulon and ULB announce the issuance by the USPTO of a first joint patent covering an antibiotic-free selection technology

Syngulon and ULB announce the issuance by the USPTO of a first joint patent covering an antibiotic-free selection technology Syngulon and ULB announce the issuance by the USPTO on March 19, 2024 of US Patent 11,932,672 covering an antibiotic-free selection technology based on bacteriocin/immunity for the production of recombinant protein or pDNA....
Read More

BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders

BioWin and MEDVIA sign first strategic collaboration between health clusters in Wallonia and Flanders The agreement will leverage strengths of two powerhouses dedicated to health to foster cross-border collaboration, building critical mass and consolidating sector to maintain Belgium’s position as a leader in Europe’s healthcare industry. Namur and Ghent, Belgium,…

Read More

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis

One2Treat launches groundbreaking treatment-decision approach to clinical research and market access analysis One2Treat reflects patient priorities in a single comprehensive treatment evaluation, reducing trial sample size and accelerating patient access to new treatments Brussels, March 26th, 2024 – One2Treat, a new innovative start-up offering cutting edge digital health solutions, launches…

Read More

PDC*line Pharma and partners receive €8.1M from Walloon region and Wallonia health cluster BioWin for personalized therapeutic vaccine project

PDC*line Pharma and partners receive €8.1M from Walloon region and Wallonia health cluster BioWin for personalized therapeutic vaccine project PDC*neo+ project aims to develop personalized therapeutic vaccine based on neoantigens for colorectal cancer Collaborative effort between biotechnology companies, PDC*line Pharma and OncoDNA, technology company salamanderU and universities UCLouvain–IREC/MIRO and ULB-BCTL…

Read More